Dr. Ailawadhi is a Professor with the Division of Hematology-Oncology at Mayo Clinic in Jacksonville. His career focus has been on treatment of plasma cell disorders with core research efforts in understanding the epidemiology and pathophysiology of these disorders, evaluating the benefit of various therapeutic strategies in different populations based on racial-ethnic and socioeconomic diversity, as well as developing novel therapeutics by means of conducting several phase 1 through phase 3 clinical trials for novel drugs including cellular therapies. He serves as the Vice Chair for CTEP’s SWOG Myeloma Committee and is a member of NCI’s Myeloma Steering Committee. Dr. Ailawadhi also leads Cancer for Mayo Clinic International (MCI) and is the Medical Director of International Advisory Services (IAS) for MCI with a focus on expanding and implementing the Mayo model of care and vision across the world.